The funding round was co-led by QED Investors and Ventures Platform.
Launched in 2022, Remedial Health aims to revolutionize healthcare access and delivery in Africa by leveraging cutting-edge technology.
The company is on a mission to digitize the pharmaceutical supply chain by providing software for pharmacies and hospitals to manage their inventory and sales.
The startup also helps pharmacies source pharmaceutical products for their shelves from major manufacturers and distributors, including GSK, Pfizer, AstraZeneca, Emzor, and Fidson Healthcare.
The newly secured capital will be used to further expand their platform’s capabilities and scale operations.
Remedial Health’s Series A funding comes during increased interest and investment in Africa’s health tech sector.
With a rapidly growing population and advancements in technology adoption across the continent, investors are recognizing the immense potential for innovative healthcare solutions.
As the healthcare landscape continues to evolve, startups like Remedial Health are at the forefront of driving innovation and leveraging technology to improve lives, making strides towards a healthier and more equitable future for Africa.
“We are delighted to partner with ISA to support the development of solar energy in Africa,” said Alain Ebobissé, CEO of Africa50. “This partnership will help to accelerate the deployment of solar energy in Africa and improve the lives of millions of Africans,” he added.
LAfricaMobile, a leading provider of cloud communication and mobile marketing solutions, has secured €4.3 million in Series A funding.
Founded in 2021, Flash offers cashless payment solutions through its scan-and-pay service, allowing consumers and businesses to make transactions conveniently using QR codes
BasiGo, a Kenyan electric bus company operating in Kenya and Rwanda, has announced a $5 million debt financing agreement with British International Investment (BII), the UK’s development finance institution and impact investor.
© 2021 Empower Africa. All rights reserved.